university website Publications by Year
  • Wealth
    • Erasmus Research Institute of Management (ERIM)
    • Erasmus School of Economics (ESE)
    • Rotterdam School of Management (RSM)
  • Health
    • Erasmus MC: University Medical Center Rotterdam
    • Erasmus School of Health Policy & Management (ESHPM)
  • Governance
    • Erasmus School of Law
    • Public Administration (FSS)
    • Netherlands Institute for Government (NIG)
    • Institute for Housing and Urban Development Studies (IHS)
  • Culture
    • Erasmus School of History, Culture and Communication (ESHCC)
    • Erasmus School of Social and Behavioural Sciences(ESSB)
    • Erasmus School of Philosophy (ESPhil)
    • International Institute of Social Studies (ISS)
  • Submissions
    • Submitting Publications
  • sign in
  • Department of Hematology /
  • Annals of Hematology /
  • Article
  • Search

E. Ammatuna (E.), M. Eefting (Matthias), K. van Lom (Kirsten), F.G. Kavelaars (François), P.J.M. Valk (Peter) and I.P. Touw (Ivo)

2015-05-01

Atypical chronic myeloid leukemia with concomitant CSF3R T618I and SETBP1 mutations unresponsive to the JAK inhibitor ruxolitinib

Publication

Publication

Annals of Hematology , Volume 94 - Issue 5 p. 879- 880

Additional Metadata
Persistent URL doi.org/10.1007/s00277-014-2272-0, hdl.handle.net/1765/91561
Journal Annals of Hematology
Organisation Department of Hematology
Citation
APA Style
  • AAA Style
  • APA Style
  • Cell Style
  • Chicago Style
  • Harvard Style
  • IEEE Style
  • MLA Style
  • Nature Style
  • Vancouver Style
  • American-Institute-of-Physics Style
  • Council-of-Science-Editors Style
  • BibTex Format
  • Endnote Format
  • RIS Format
  • CSL Format
  • DOIs only Format
Ammatuna, E., Eefting, M., van Lom, K., Kavelaars, F., Valk, P., & Touw, I. (2015). Atypical chronic myeloid leukemia with concomitant CSF3R T618I and SETBP1 mutations unresponsive to the JAK inhibitor ruxolitinib. Annals of Hematology, 94(5), 879–880. doi:10.1007/s00277-014-2272-0
  • View at Publisher
  • View at Pubmed
  • View at Scopus


Sign in to view additional files

See Also
article
Erratum to: Atypical chronic myeloid leukemia with concomitant CSF3R T618I and SETBP1 mutations unresponsive to the JAK inhibitor ruxolitinib[Annals of Hematology, (2015), DOI:10.1007/s00277-014-2272-0]
E. Ammatuna (E.), M. Eefting (Matthias), K. van Lom (Kirsten), F.G. Kavelaars (François), P.J.M. Valk (Peter) and I.P. Touw (Ivo)

university website
  • About

    • Research Matters
    • Open Access
    • Privacy Statement
artudis website

Workflow

Workflow

Add Content


User Publication Person Organisation Collection
Close